BR9915610A - Preparações farmacêuticas combinadas - Google Patents

Preparações farmacêuticas combinadas

Info

Publication number
BR9915610A
BR9915610A BR9915610-5A BR9915610A BR9915610A BR 9915610 A BR9915610 A BR 9915610A BR 9915610 A BR9915610 A BR 9915610A BR 9915610 A BR9915610 A BR 9915610A
Authority
BR
Brazil
Prior art keywords
combined pharmaceutical
pharmaceutical preparations
pharmaceutically
salt
hydrochlorothiazide
Prior art date
Application number
BR9915610-5A
Other languages
English (en)
Inventor
Rudolf Heller
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8233041&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9915610(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9915610A publication Critical patent/BR9915610A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: <B>"PREPARAçõES FARMACêUTICAS COMBINADAS"<D>. A presente invenção refere-se a preparação farmacêutica combinada para tratamento de distúrbios cardíacos e cardiovasculares como hipertensão, angina pectoris, insuficiência cardíaca e doenças associadas com as mesmas, contendo as substâncias ativas carvedilol ou um sal farmaceuticamente aceitável do mesmo e hidroclorotiazida ou um sal farmaceuticamente aceitável da mesma, bem como aditivos farmaceuticamente usuais.
BR9915610-5A 1998-11-27 1999-11-20 Preparações farmacêuticas combinadas BR9915610A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98122489 1998-11-27
PCT/EP1999/008972 WO2000032174A2 (en) 1998-11-27 1999-11-20 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide

Publications (1)

Publication Number Publication Date
BR9915610A true BR9915610A (pt) 2001-08-14

Family

ID=8233041

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915610-5A BR9915610A (pt) 1998-11-27 1999-11-20 Preparações farmacêuticas combinadas

Country Status (22)

Country Link
US (3) US6403579B1 (pt)
EP (1) EP1131072B1 (pt)
JP (2) JP2002531395A (pt)
KR (1) KR100421347B1 (pt)
CN (1) CN1184971C (pt)
AR (1) AR020287A1 (pt)
AT (1) ATE238056T1 (pt)
AU (1) AU765977B2 (pt)
BR (1) BR9915610A (pt)
CA (1) CA2352361C (pt)
CO (1) CO5011053A1 (pt)
DE (1) DE69907252T2 (pt)
DK (1) DK1131072T3 (pt)
ES (1) ES2195638T3 (pt)
MY (1) MY121831A (pt)
PE (1) PE20001302A1 (pt)
PT (1) PT1131072E (pt)
TR (3) TR200200982T2 (pt)
TW (1) TWI228414B (pt)
UY (1) UY25821A1 (pt)
WO (1) WO2000032174A2 (pt)
ZA (1) ZA200104280B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
CA2426811A1 (en) * 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
IN191028B (pt) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
EP1499310A4 (en) * 2002-04-30 2005-12-07 Sb Pharmco Inc MONOCITRATE MONOHYDRATE OF CARVEDILOL
US20050261355A1 (en) 2002-06-27 2005-11-24 Sb Pharmco Puerto Rico Inc., Carvedilol hydobromide
MXPA04012923A (es) 2002-06-27 2005-03-31 Sb Pharmco Inc Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento.
WO2004041252A1 (en) 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
EP2301526B1 (en) 2003-03-26 2016-03-23 Egalet Ltd. Morphine controlled release system
EP1615888A1 (en) * 2003-04-21 2006-01-18 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
AU2003272851A1 (en) * 2003-09-26 2005-04-14 Shuyi Zhang Sustained release preparation containing hydrochlorothiazide
JP2007512372A (ja) 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法
US20050175695A1 (en) * 2003-11-25 2005-08-11 Catherine Castan Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
ES2285549T3 (es) * 2003-12-02 2007-11-16 Nicox S.A. Derivados nitroxxi de carvedidol y otros beta bloqueantes utilizados como medicamentos antihipertensores.
KR20070094666A (ko) * 2005-02-25 2007-09-20 에프. 호프만-라 로슈 아게 약제 물질 분산성이 향상된 정제
CA2836545C (en) 2006-06-16 2016-08-09 Lek Pharmaceuticals D.D. Pharmaceutical composition comprising telmisartan and hydrochlorothiazide
GB0612540D0 (en) 2006-06-23 2006-08-02 Novartis Ag Galenical formulations of organic compounds
WO2008114276A1 (en) * 2007-03-16 2008-09-25 Lupin Limited Novel oral controlled release composition of carvedilol
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations
BR112012022775A2 (pt) * 2010-03-10 2016-07-19 Nogra Pharma Ltd composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2643556B1 (fr) * 1989-02-27 1993-03-05 Sanofi Sa Composition pharmaceutique a liberation prolongee d'acide valproique
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
ES2106818T3 (es) * 1991-10-30 1997-11-16 Glaxo Group Ltd Composicion multicapa que contiene antagonistas de histamina o secotina.
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
FR2752162B1 (fr) * 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida

Also Published As

Publication number Publication date
TR200101470T2 (tr) 2001-11-21
WO2000032174A2 (en) 2000-06-08
KR100421347B1 (ko) 2004-03-06
EP1131072A2 (en) 2001-09-12
CA2352361C (en) 2007-01-02
AU765977B2 (en) 2003-10-09
EP1131072B1 (en) 2003-04-23
ZA200104280B (en) 2002-08-26
AU1506500A (en) 2000-06-19
TR200200981T2 (tr) 2002-06-21
ES2195638T3 (es) 2003-12-01
ATE238056T1 (de) 2003-05-15
MY121831A (en) 2006-02-28
KR20010080578A (ko) 2001-08-22
TWI228414B (en) 2005-03-01
US20020052367A1 (en) 2002-05-02
PE20001302A1 (es) 2000-11-30
TR200200982T2 (tr) 2002-06-21
DK1131072T3 (da) 2003-08-11
US20040087578A1 (en) 2004-05-06
DE69907252D1 (de) 2003-05-28
CA2352361A1 (en) 2000-06-08
DE69907252T2 (de) 2004-01-29
US6403579B1 (en) 2002-06-11
WO2000032174A3 (en) 2000-11-16
JP2007077160A (ja) 2007-03-29
PT1131072E (pt) 2003-08-29
CN1184971C (zh) 2005-01-19
CN1328460A (zh) 2001-12-26
AR020287A1 (es) 2002-05-02
UY25821A1 (es) 2001-07-31
CO5011053A1 (es) 2001-02-28
JP2002531395A (ja) 2002-09-24

Similar Documents

Publication Publication Date Title
BR9915610A (pt) Preparações farmacêuticas combinadas
BG104075A (en) Combined treatment including atorvastatin and an antihypertonic form
BR9812030A (pt) Combinações terapêuticas compreendendo amlodipina e atorvastatina
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
BR9909192A (pt) Preparações galênicas de meloxicam para administração oral
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
NO20100569L (no) Farmasoytiske formuleringer og anvendelse derav i forebyggelsen av slag, diabetes og/eller kongestivt hjertesvikt
EA200300155A1 (ru) Терапевтическая комбинация ингибитора сетр и аторвастатина
EA012325B1 (ru) Терапевтические составы для лечения болезней, связанных с наличием бета-амилоида
HUP0104249A2 (hu) Szív és érrendszeri betegségekkel összefüggő megbetegedési és halálozási arányok csökkentésére szolgáló gyógyszerkészítmény angiotenzin átalakító enzim inhibitor és aldoszteron antagonista együttes alkalmazásával
BRPI0412262A (pt) derivados de azepina como agentes farmacêuticos
DE50011582D1 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
ATE282418T1 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
DE59811158D1 (de) Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen
PT998287E (pt) Utilizacao de levobupivacaina
HU226022B1 (en) Process for preparation pharmaceutical composition combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
EP0752249A3 (fr) Utilisation d&#39;un antagoniste de l&#39;angiotensine II et d&#39;un dérivé du benzofurane à activité antiarythmique pour la préparation d&#39;un médicament utile dans le traitement des affections cardiovasculaires
DE50110262D1 (de) Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen
KR0131452B1 (ko) 양성 전립선 비대증 경우의 배뇨장애 치료용 나프토피딜
JPWO2002030425A1 (ja) 糖尿病合併症予防・治療剤
KR20050121236A (ko) 치매 환자에서 초조 증상을 치료하기 위한 카르바마제핀유도체의 용도
HUP0000108A2 (hu) Angiotenzin II antagonisták alkalmazása szimptómás szívelégtelenség kezelésére alkalmas gyógyászati készítmény előállítására
AU2002363874A1 (en) Use of desoxypeganine for treating clinical depression

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/549, A61K 31/403, A61K 9/28

Ipc: A61K 31/549 (2008.04), A61K 31/403 (2008.04), A61K

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11,13 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.